Bisanzio Donal, Estofolete Cássia Fernanda, Reithinger Richard
International Development Group, RTI International, Washington D.C., USA.
Laboratório de Pesquisas em Virologia, FAMERP, CREATE-NEO, São José do Rio Preto, São Paulo, Brazil.
Int Health. 2025 Jul 1;17(4):597-599. doi: 10.1093/inthealth/ihae089.
Dengue is of growing global public health concern. Diabetes is a significant risk factor for severe dengue and dengue-related mortality. Countries with the highest number of reported dengue cases are projected to experience a substantial increase in diabetes by 2050. This likely will result in an increased incidence of dengue-diabetes comorbidity, and, hence, in severe dengue and dengue-related mortality. Countries that are or will be affected by a high burden for both diabetes and dengue should urgently design strategies to minimize the health and economic impact that a diabetes-dengue comorbidity could have on affected populations.
登革热日益引起全球公共卫生关注。糖尿病是严重登革热及登革热相关死亡的一个重要风险因素。预计到2050年，登革热报告病例数最多的国家糖尿病患者数量将大幅增加。这可能会导致登革热与糖尿病合并症的发病率上升，进而导致严重登革热及登革热相关死亡病例增加。目前或未来受糖尿病和登革热高负担影响的国家应紧急制定战略，以尽量减少糖尿病与登革热合并症可能对受影响人群造成的健康和经济影响。
